NEW YORK (GenomeWeb News) – Bioké has signed an agreement to distribute Trinean products in the Netherlands and Germany, the firms announced today.

Trinean's Xpose 'Touch & Go" platform is for quantifying DNA, RNA, and proteins, while the DropSense96 instrument quantifies DNA, RNA, and proteins without dyes in a microvolume 96-well format.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.